Sudeep Pharma IPO Sees Strong Day-2 Demand as Subscription Crosses 2.5x

Sudeep Pharma’s IPO is subscribed 2.5x on Day 2, with strong retail and NII demand and a GMP near 19%, indicating a potentially strong listing.

positive
Recently

Sudeep Pharma IPO Sees Strong Day-2 Demand as Subscription Crosses 2.5x

1 min read85 words
Sudeep Pharma IPO Sees Strong Day-2 Demand as Subscription Crosses 2.5x
Sudeep Pharma’s IPO is subscribed 2.
Sudeep Pharma’s ₹895 crore IPO continued to attract strong interest on Day 2, with total bids exceeding 2.5 times the offer size by late morning. The Vadodara-based manufacturer of excipients and specialty ingredients received nearly 2.6 crore bids against the 1.06 crore shares on offer. Retail investors subscribed their quota almost 3x, while NIIs oversubscribed more than 5x. QIB participation stood at 10% so far. The IPO is priced at ₹563–₹593 per share and includes a ₹95 crore fresh issue and an ₹800 crore OFS.
Sentinel